Application number | Title of the application | Filing Date | Status |
---|
09/857169 | Preparations for intraurethral administration | Oct 16, 2001 | Abandoned |
Array
(
[id] => 6159120
[patent_doc_number] => 20020147219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Neurokinin antagonists'
[patent_app_type] => new
[patent_app_number] => 09/981025
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5784
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147219.pdf
[firstpage_image] =>[orig_patent_app_number] => 09981025
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/981025 | Neurokinin antagonists | Oct 15, 2001 | Issued |
Array
(
[id] => 1063342
[patent_doc_number] => 06849749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-01
[patent_title] => 'Method for the preparation of citalopram'
[patent_app_type] => utility
[patent_app_number] => 09/977920
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4467
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849749.pdf
[firstpage_image] =>[orig_patent_app_number] => 09977920
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/977920 | Method for the preparation of citalopram | Oct 14, 2001 | Issued |
Array
(
[id] => 6062981
[patent_doc_number] => 20020031559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Herbal suppositories'
[patent_app_type] => new
[patent_app_number] => 09/974452
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5183
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20020031559.pdf
[firstpage_image] =>[orig_patent_app_number] => 09974452
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/974452 | Herbal suppositories | Oct 8, 2001 | Abandoned |
Array
(
[id] => 6243497
[patent_doc_number] => 20020045745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Pharmaceutically acceptable starch'
[patent_app_type] => new
[patent_app_number] => 09/970648
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9428
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045745.pdf
[firstpage_image] =>[orig_patent_app_number] => 09970648
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/970648 | Pharmaceutically acceptable starch | Oct 4, 2001 | Issued |
Array
(
[id] => 5969078
[patent_doc_number] => 20020091113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Treatment of septic shock'
[patent_app_type] => new
[patent_app_number] => 09/971079
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2297
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20020091113.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971079
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971079 | Treatment of septic shock | Oct 4, 2001 | Abandoned |
Array
(
[id] => 1204609
[patent_doc_number] => 06716420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-06
[patent_title] => 'Methods of use and of making a mascara comprising at least one coloring agent and at least one heteropolymer'
[patent_app_type] => B2
[patent_app_number] => 09/971028
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10838
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/716/06716420.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971028
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971028 | Methods of use and of making a mascara comprising at least one coloring agent and at least one heteropolymer | Oct 4, 2001 | Issued |
Array
(
[id] => 5923040
[patent_doc_number] => 20020115619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Compositions and methods for treatment of cystic fibrosis'
[patent_app_type] => new
[patent_app_number] => 09/970843
[patent_app_country] => US
[patent_app_date] => 2001-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15619
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115619.pdf
[firstpage_image] =>[orig_patent_app_number] => 09970843
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/970843 | Compositions and methods for treatment of cystic fibrosis | Oct 3, 2001 | Abandoned |
Array
(
[id] => 1150767
[patent_doc_number] => 06770678
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-03
[patent_title] => 'Lyophilisates having improved reconstitutability'
[patent_app_type] => B1
[patent_app_number] => 09/889930
[patent_app_country] => US
[patent_app_date] => 2001-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1721
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770678.pdf
[firstpage_image] =>[orig_patent_app_number] => 09889930
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/889930 | Lyophilisates having improved reconstitutability | Oct 2, 2001 | Issued |
Array
(
[id] => 6611441
[patent_doc_number] => 20020064509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Method for producing a goniochromatic effect comprising applying to skin a cosmetic composition comprising at least one continuous lipophilic phase and at least one goniochromatic pigment'
[patent_app_type] => new
[patent_app_number] => 09/968967
[patent_app_country] => US
[patent_app_date] => 2001-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5462
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20020064509.pdf
[firstpage_image] =>[orig_patent_app_number] => 09968967
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/968967 | Method for producing a goniochromatic effect comprising applying to skin a cosmetic composition comprising at least one continuous lipophilic phase and at least one goniochromatic pigment | Oct 2, 2001 | Abandoned |
Array
(
[id] => 6800773
[patent_doc_number] => 20030095937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Method for stimulating hair growth by administering vitamin D analogs'
[patent_app_type] => new
[patent_app_number] => 09/969380
[patent_app_country] => US
[patent_app_date] => 2001-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6522
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20030095937.pdf
[firstpage_image] =>[orig_patent_app_number] => 09969380
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/969380 | Method for stimulating hair growth by administering vitamin D analogs | Oct 1, 2001 | Abandoned |
09/868989 | USE OF UNSAPONIFIABLE COMPONENTS OF VEGETABLE OILS FOR PREPARING A FOOD ADDITIVE | Oct 1, 2001 | Abandoned |
Array
(
[id] => 6860515
[patent_doc_number] => 20030091523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Hair treatment compositions which provide hair body and which comprise silicone pressure sensitive adhesives'
[patent_app_type] => new
[patent_app_number] => 09/968214
[patent_app_country] => US
[patent_app_date] => 2001-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11072
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091523.pdf
[firstpage_image] =>[orig_patent_app_number] => 09968214
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/968214 | Hair treatment compositions which provide hair body and which comprise silicon pressure sensitive adhesives | Sep 30, 2001 | Issued |
Array
(
[id] => 5935460
[patent_doc_number] => 20020061319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Film-forming cosmetic composition'
[patent_app_type] => new
[patent_app_number] => 09/965792
[patent_app_country] => US
[patent_app_date] => 2001-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7048
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061319.pdf
[firstpage_image] =>[orig_patent_app_number] => 09965792
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/965792 | Film-forming cosmetic composition | Sep 30, 2001 | Abandoned |
Array
(
[id] => 1241242
[patent_doc_number] => 06683065
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-27
[patent_title] => 'Method of treating body insect infestation'
[patent_app_type] => B1
[patent_app_number] => 09/937627
[patent_app_country] => US
[patent_app_date] => 2001-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2438
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/683/06683065.pdf
[firstpage_image] =>[orig_patent_app_number] => 09937627
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/937627 | Method of treating body insect infestation | Sep 26, 2001 | Issued |
Array
(
[id] => 971880
[patent_doc_number] => 06936265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-30
[patent_title] => 'PREPARATIONS OF THE W/O EMULSION TYPE WITH AN INCREASED WATER CONTENT BASED ON LOW-VISCOSITY, READILY SPREADABLE LIPID COMPONENTS, ADDITIONALLY COMPRISING ONE OR MORE ALKYLMETHICONE COPOLYOLS AND/OR ALKYLDIMETHICONE COPOLYOLS'
[patent_app_type] => utility
[patent_app_number] => 09/963161
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6374
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/936/06936265.pdf
[firstpage_image] =>[orig_patent_app_number] => 09963161
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/963161 | PREPARATIONS OF THE W/O EMULSION TYPE WITH AN INCREASED WATER CONTENT BASED ON LOW-VISCOSITY, READILY SPREADABLE LIPID COMPONENTS, ADDITIONALLY COMPRISING ONE OR MORE ALKYLMETHICONE COPOLYOLS AND/OR ALKYLDIMETHICONE COPOLYOLS | Sep 25, 2001 | Issued |
Array
(
[id] => 6658263
[patent_doc_number] => 20030133900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Emollient skin conditioning cream and method'
[patent_app_type] => new
[patent_app_number] => 09/964143
[patent_app_country] => US
[patent_app_date] => 2001-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9888
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0133/20030133900.pdf
[firstpage_image] =>[orig_patent_app_number] => 09964143
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/964143 | Emollient skin conditioning cream and method | Sep 24, 2001 | Issued |
09/914270 | Use of r-aryl propionic acids for producing medicaments to treat diseases in humans and animals, whereby said diseases can be therapeutically influenced by inhibiting the activation of nf-kb | Sep 23, 2001 | Abandoned |
Array
(
[id] => 6178189
[patent_doc_number] => 20020156122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent'
[patent_app_type] => new
[patent_app_number] => 09/960471
[patent_app_country] => US
[patent_app_date] => 2001-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 16833
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20020156122.pdf
[firstpage_image] =>[orig_patent_app_number] => 09960471
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/960471 | Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent | Sep 18, 2001 | Abandoned |
Array
(
[id] => 5815250
[patent_doc_number] => 20020040039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-04
[patent_title] => 'Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist'
[patent_app_type] => new
[patent_app_number] => 09/955379
[patent_app_country] => US
[patent_app_date] => 2001-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9675
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20020040039.pdf
[firstpage_image] =>[orig_patent_app_number] => 09955379
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/955379 | Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist | Sep 17, 2001 | Abandoned |